Silibinin, a novel chemokine receptor type 4 antagonist, inhibits chemokine ligand 12-induced migration in breast cancer cells.

Wang Y, Liang WC, Pan WL, Law WK, Hu JS, Ip DT, Waye MM, Ng TB, Wan DC
Phytomedicine. 2014 Sep 25;21(11):1310-7. doi: 10.1016/j.phymed.2014.06.018. Epub 2014 Jul 30. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.